Schedule 13D ownership disclosure
OYSTER POINT PHARMA INC
Security class unavailable · CUSIP: 69242L106
Event date: 2019-11-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-292361
- Form type
- SC 13D
- Filer
- InvOpps GP IV, L.L.C.
- CIK
- CIK 1792570
- Filed
- Nov 14, 2019
- Reporting period
- Nov 04, 2019
- Description
- Schedule 13D beneficial ownership